Pace® expert to leverage extensive knowledge to provide guidance on risk assessments for pharmaceutical and biopharmaceutical companies
Read More
Finetech, a top manufacturer of pharmaceutical machinery, announces its new technology for the NJP 1200 capsule filling machine. This machine can fuse soft capsule + granule into one hard capsule.
Read MoreCurrent FX rates indicate that the LTM August 2025 Revenue would be approximately $58M with $6M in EBITDA
Sportstech announced May to August 2025 revenue growth of 20% YOY
TRNR Investment in Sportstech working capital is accelerating growth for the pending acquisition, with full-year 2025 Revenue growth expected to exceed 30%
Strong Business Momentum and Profitable Growth Reinforces Underscore Target's Operational Strength and Logic of Acquisition in advance of Closing
Read MoreNew candidates, APVO452 and APVO451, harness proprietary ADAPTIR-FLEXTM design to target prostate and multiple solid tumor cancers by simultaneously engaging tumor antigens, T cells, and immunosuppressive cells
Mipletamig-driven clinical validation of the CRIS-7-derived CD3 binding domain underpins Aptevo's introduction of new, trispecific CD3-directed anti-cancer molecules
Read More
New Data Describe Lab-Grown Amebocytes (aLAL™) That Aim to Match Native LAL Performance While Solving Supply, Cost and Sustainability Constraints
Read More
Virtue Recovery has expanded its Business Development Team with the addition of two American Veterans, Adam Khosroabadi and Chauncy Nash. Both bring extensive military service, professional expertise, and a passion for helping others, strengthening Virtue Recovery's mission to provide compassionate, whole-person treatment across its nationally accredited centers.
Read More
Aspire's sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes after dosing
TxB2 is a biomarker indicating aspirin's effect on platelet aggregation, the clumping of platelets that leads to dangerous blood clots
This rapid inhibition is critical during suspected heart attacks, when clots blocking heart arteries can cause permanent muscle damage
Lab results showed Aspire's product acted approximately twice as fast as the current recommendation for chewed aspirin tablet treatment
These clinical trial results enable a potential regulatory submission for accelerated approval on track for Q3 2025
"A shift to Schedule III could unlock a $30+ billion market, eliminate crippling 280E tax burdens, unleash institutional investment, and set the stage for explosive industry-wide growth."
Read More- Industry veteran brings extensive senior level leadership and expertise in biologics development, strategic partnerships, mergers and acquisitions across biotech and large pharma organizations
- Operating experience to significantly enhance development program of CID-103 (anti-CD38 mAb)
Read More
After the EPA dismissed employees who publicly criticized its leadership, attention is turning to the Drug Enforcement Administration's Diversion Control Division, long accused of obstructing FDA-approved cannabis research. With DEA officials Matthew Strait and Thomas Prevoznik retired and attorney Aarathi Haig facing ethical questions, patient advocates warn that new DEA Administrator Terry Cole may soon be forced to take similar disciplinary action against insiders who blocked MMJ BioPharma Cultivation's clinical trials for Huntington's disease and Multiple Sclerosis.
Read More
In the first half of 2025, 88% of boards required ROI projections for all new IT projects, and more than half of U.S. hospitals (52%) delayed or canceled initiatives with ROI timelines longer than 24 months.
Read More
Facial plastic surgeons at Becker Plastic Surgery explain how the deep plane facelift differs from traditional techniques, focusing on repositioning deeper tissues to address advanced mid-face and neck aging.
Read MoreCompany to host webcast today at 8.00 a.m. ET
Growing portfolio of RNA delivery clients and programs
Advancing plans for partial spin-off of RNA delivery activities
Continued adjustment of cost structure
Learn How Brello Health's Telehealth GLP-1 Weight Loss Program Combines Semaglutide, Tirzepatide, and Expert Coaching for Safe, Sustainable Results in 2025
Read More
Justice Delayed Is Justice Denied
The retirement of Matthew Strait and Thomas Prevoznik is not closure-it is the beginning of a reckoning with the DEA's culture of obstruction.
"Thomas Prevoznik may have pulled the trigger, but Matthew Strait loaded the gun," said Duane Boise, CEO of MMJ International Holdings. "Now the question is whether Administrator Cole will keep allowing Aarathi Haig to pull the strings, or whether he'll finally restore constitutional accountability. Patients' lives depend on it."
The Seven Year Regulatory Ordeal Blocking Medical Innovation
Read MoreIn vitro findings reveal Telomir-1's dual action: targeting DNA methylation switches and cutting into the Wnt "fuel line" that drives cancer growth.
Read More
